Pavitra Dewda | Clinical Pharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. Pavitra Dewda | Clinical Pharmacology | Best Researcher Award

Dr. Pavitra Dewda, GSK – GlaxoSmithKline, Belgium

Dr. Pavitra Dewda is a seasoned Global Medical Director with over a decade of experience in the pharmaceutical and biotechnology industries, specializing in medical strategy, clinical development, and vaccine lifecycle management. Currently at GlaxoSmithKline, she leads global medical strategies for vaccines, focusing on hepatitis, pertussis, and pneumococcal vaccines. Previously, she held leadership roles at Merck KGaA and Sanofi Pasteur, driving initiatives in medical affairs and scientific engagement. Dr. Dewda has been recognized with multiple global awards for her contributions to vaccine education, regulatory affairs, and medical strategy. πŸŒπŸ’‰πŸ’ŠπŸ“ˆπŸ‘©β€πŸ”¬

 

Publication Profile

Scopus

Education & Professional Development

 

Dr. Pavitra Dewda holds an MD from Padmashree Dr. D.Y. Patil University, Pune (2011), and an MBBS from Maharashtra University of Medical Science (2005). Her strong educational foundation in medicine has enabled her to excel in the global pharmaceutical industry. With a passion for medical strategy and vaccine development, Dr. Dewda continues to enhance her expertise through ongoing professional development in clinical affairs, regulatory management, and public health. Her education forms the bedrock for her impactful career in global medical leadership. πŸŽ“πŸ’‰πŸ“šπŸ‘©β€βš•οΈ

Executive Career Synopsis & Highlights

Dr. Pavitra Dewda is a seasoned global medical leader, currently serving as Global Medical Director at GlaxoSmithKline (GSK) since December 2022. She leads global medical lifecycle accountability for key vaccine portfolios, including hepatitis and pertussis, and drives strategic partnerships, advocacy, and medical strategy. Previously, she was General Manager Medical at GSK India, where she led medical operations, secured regulatory approvals, and executed successful vaccine launches. Dr. Dewda has also held leadership roles at Sanofi and Merck KGaA, excelling in medical affairs, strategic initiatives, and digital transformation, receiving multiple awards for her innovative contributions. πŸ’‰πŸŒπŸŽ“

 

Research Focus

Dr. Pavitra Dewda’s research focuses primarily on vaccinology πŸ¦ πŸ’‰, infectious diseases 🦠, medical affairs 🩺, and fertility medicine πŸ‘Ά. She has contributed to studies on hepatitis A and B vaccination for at-risk adults in Europe, emphasizing healthcare professionals’ knowledge, attitudes, and practices. Dr. Dewda also co-authored research on vaccinating healthcare providers in India, showcasing the importance of immunization in healthcare settings. Additionally, she has explored fertility treatments 🌱, particularly in in vitro fertilization (IVF) outcomes, demonstrating her expertise in both public health and reproductive health. Her work blends clinical research and medical strategy.

 

Publication Top Notes

  • “Knowledge, Attitudes, and Practices of European Healthcare Professionals towards Hepatitis A and Hepatitis B Vaccination in at-Risk Adults” – Vaccines, 2023, 11(11), 1645 πŸ¦ πŸ’‰ | Cited by: 1
  • “A Modern Perspective on Vaccinating Healthcare Service Providers in India: A Narrative Review” – Infectious Diseases and Therapy, 2022, 11(1), 81–99 πŸ©ΊπŸ’‰ | Cited by: 5
  • “Association between progesterone elevation on the day of human chronic gonadotropin trigger and pregnancy outcomes after fresh embryo transfer in in vitro fertilization/intracytoplasmic sperm injection cycles” – Frontiers in Endocrinology, 2018, 9(APR), 201 πŸ‘Άβš—οΈ | Cited by: 23

 

 

Keun Hyung Park | Clinical Research | Best Researcher Award

Posted on by ScienceFather

Dr. Keun Hyung Park | Clinical Research | Best Researcher Award

Dr. Keun Hyung Park, Sunjin Clinical Research Center (SCRC), Sunjin BeautyScience Co., Ltd., South Korea

Dr. Keun Hyung Park is an accomplished expert in genetic engineering and immunology, with a PhD from Kyung Hee University (2014). He currently serves as the Head of Sunjin Clinical Research Center and is an advisory committee member at Korea Bio Research Center. Dr. Park has published extensively on skin science, wound healing, and inflammation, contributing to top journals like J Immunol and Skin Research & Technology. He is also a recognized voice in the cosmetics industry through his insightful columns on K-beauty trends. πŸ§¬πŸ’ΌπŸ’‘ His expertise spans molecular biology, clinical research, and dermatological studies.

Publication profile

Scopus

Education πŸŽ“

Dr. Keun Hyung Park holds advanced degrees in Genetic Engineering with a focus on Immunology from Kyung Hee University. He earned his Master’s degree in 2008, gaining a strong foundation in molecular biology and immunology. Continuing his academic journey, he completed his PhD in 2014, further specializing in immunology-related genetic engineering. His extensive education has equipped him with the expertise to contribute significantly to the fields of molecular biology, clinical research, and dermatology, positioning him as a leader in both academic and industry settings. πŸ§¬πŸ“š

 

Professional Experience πŸ§‘β€πŸ”¬

Dr. Keun Hyung Park is currently the Head of SUNJIN Clinical Research Center, where he serves as Director and Principal Investigator (PI) since 2024. He is also a member of the expert committee for Cosinkorea and an advisory committee member of the Korea Bio Research Center. Previously, he was a lecturer in molecular biology at Kyung Hee University (2012-2013) and led the safety clinical team at IEC Korea (2014-2020). He held key roles in skin clinical consulting, including at THE K BEAUTY SCIENCE and OATC Skin Clinical Trial Center. 🧫🧴

 

Research Focus

Dr. Keun Hyung Park’s research primarily focuses on immunology and inflammation, particularly the molecular mechanisms underlying inflammatory responses and their modulation. His work explores the role of natural compounds in attenuating inflammation and promoting angiogenesis. Dr. Park investigates signaling pathways such as MAPK and NF-ΞΊB, contributing to our understanding of how these pathways influence immune cell behavior and tissue healing. Additionally, he examines the effects of various natural extracts on cellular processes, emphasizing their potential therapeutic applications in treating inflammatory diseases and enhancing wound healing. His research has significant implications for developing innovative treatments in biomedicine. πŸ§¬πŸŒΏπŸ’‰

 

Publication Top Notes

  • Cynandione A attenuates lipopolysaccharide-induced production of inflammatory mediators via MAPK inhibition and NF-ΞΊB inactivation in RAW264.7 macrophages and protects mice against endotoxin shock (30 citations) – 2015 🐭
  • Jaceosidin, a natural flavone, promotes angiogenesis via activation of VEGFR2/FAK/PI3K/AKT/NF-ΞΊB signaling pathways in endothelial cells (28 citations) – 2014 🌱
  • The stimulatory effects of Stewartia koreana extract on the proliferation and migration of fibroblasts and the wound healing activity of the extract in mice (20 citations) – 2014 🩹
  • Enhancement of CCL15 expression and monocyte adhesion to endothelial cells (ECs) after hypoxia/reoxygenation and induction of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs (33 citations) – 2013 πŸ”¬
  • Human lactoferrin suppresses TNF-Ξ±-induced intercellular adhesion molecule-1 expression via competition with NF-ΞΊB in endothelial cells (31 citations) – 2012 🧬

 

 

MΓ©rcia Medeiros | Health Professions | Women Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. MΓ©rcia Medeiros | Health Professions | Women Researcher Award

Assoc Prof Dr. MΓ©rcia Medeiros, UNIVERSIDADE FEDERAL DE ALAGOAS, Brazil

Suitability for Research for Women Researcher Award

Associate Professor Dr. MΓ©rcia Medeiros appears to be a strong candidate for the Research for Women Researcher Award. Her distinguished career and extensive contributions to pediatrics and medical education align well with the award’s criteria, which often recognize outstanding research and contributions by women in their respective fields.

Publication profile

Google Scholar

Education and Academic Background

Dr. Medeiros holds a PhD in Sciences Applied to Pediatrics from the Federal University of SΓ£o Paulo, where her research focused on the prevalence of wheezing in infants and associated risk factors. She also has a Master’s degree in Child Health from the Federal University of Alagoas and various specializations, including in Medical Education and Health Education for SUS Preceptors.

Professional Experience

Dr. Medeiros is an Associate Professor III at the Faculty of Medicine, Federal University of Alagoas (FAMED/UFAL), and is actively involved in the Postgraduate Program in Medical Sciences and the Professional Master’s Degree in Teaching in Health. She coordinates the Adolescent Medicine service and serves as a preceptor for the Pediatrics residency program.

Research Focus

Her research focuses on chronic diseases in pediatrics, allergic respiratory diseases, adolescent health, and medical education. This includes significant work on bronchial asthma and its impact on school performance, showcasing her commitment to addressing key issues in pediatric health and education.

Leadership and Involvement

Dr. Medeiros has held various leadership roles, including deputy director of the Faculty of Medicine and deputy coordinator of the Medicine course. She is also a member of the Department of School Health of the Brazilian Society of Pediatrics.

Publication Top Notes

  • Prevalence of asthma and allergic diseases in adolescents: nine-year follow-up study (2003-2012) – Jornal de Pediatria 91, 30-35 πŸ“Š – Cited by: 111, Year: 2015
  • A extensΓ£o universitΓ‘ria e a promoção da saΓΊde no Brasil: revisΓ£o sistemΓ‘tica – Revista Portal: SaΓΊde e Sociedade 3 (3), 921-930 πŸ” – Cited by: 15, Year: 2019
  • PrevalΓͺncia de asma brΓ΄nquica em escolares e adolescentes do municΓ­pio de MaceiΓ³ – Pediatria (SΓ£o Paulo), 95-102 🌟 – Cited by: 7, Year: 2005
  • Medical residents’ perceptions of a pediatric residency program in a public university hospital – Interface-Comunicação, SaΓΊde, Educação 25, e210215 πŸ’¬ – Cited by: 6, Year: 2021
  • A prΓ‘tica pedagΓ³gica ea permanΓͺncia de cotistas Afrodescendente no curso de odontologia – New Trends in Qualitative Research 2, 658-674 πŸ“š – Cited by: 5, Year: 2020
  • PrevalΓͺncia de asma e doenΓ§as alΓ©rgicas em adolescentes: estudo evolutivo de nove anos (2003 a 2012) – Jornal de Pediatria 91, 30-35 πŸ“Š – Cited by: 5, Year: 2015
  • O Processo Ensino Aprendizagem nos cenΓ‘rios de PrΓ‘tica: Concepçáes dos Docentes do Curso de Graduação em Enfermagem – CIAIQ2016 2, 4 🏫 – Cited by: 4, Year: 2016
  • Asma brΓ΄nquica e desempenho escolar em crianΓ§as e adolescentes de MaceiΓ³, AL – Pediatria (SΓ£o Paulo), 149-156 πŸ“– – Cited by: 4, Year: 2003
  • Metodologias ativas no processo ensino aprendizagem na Γ‘rea de neurologia – CONHECIMENTO & DIVERSIDADE 9 (19), 27-36 🧠 – Cited by: 3, Year: 2018
  • PrevalΓͺncia de asma e rinite entre adolescentes de 13-14 anos em uma capital do Nordeste, de acordo com o questionΓ‘rio do International Study of Asthma and Allergies in Children – Arquivos de Asma, Alergia e Imunologia 2 (3), 112-118 🌿 – Cited by: 3, Year: 2014


Conclusion

Given Dr. Medeiros’s significant contributions to pediatric research, medical education, and her leadership roles, she would be a fitting recipient of the Research for Women Researcher Award. Her dedication to advancing pediatric health and education, combined with her impactful research, highlights her suitability for this recognition.

James Melrose | Health Professions | Best Researcher Award

Posted on by ScienceFather

Prof. James Melrose | Health Professions | Best Researcher Award

Prof. James Melrose, The University of Sydney, Australia

Based on the provided information, Prof. James Melrose appears to be a highly suitable candidate for the Research for Best Researcher Award. Here’s an evaluation of his qualifications:

Publication profile

Academic and Research Excellence

Prof. Melrose has a solid educational background with a B.Sc (Hons) in Biochemistry and a Ph.D. focused on carbohydrate metabolizing enzymes associated with barley. His long-standing affiliation with prestigious institutions such as The University of Sydney and the University of New South Wales highlights his strong academic and research credentials. Over a period of three decades, he has contributed significantly to bone and joint research, particularly in biochemical and immunological studies.

Special Awards and Recognitions

Prof. Melrose has received numerous prestigious awards throughout his career, demonstrating his recognition by the scientific community. Notable awards include the Smith and Nephew Award for his work on the spine, the Matrix Biology Society’s best poster award, and the European Spine Society’s GRAMMER Award. These accolades emphasize his contributions to the field of spine research and matrix biology, marking him as a leading researcher.

Teaching and Mentorship

Prof. Melrose has a strong background in teaching and mentorship, having served as a laboratory demonstrator, lecturer, and co-supervisor of Ph.D. students. His involvement in training and supervising research personnel at the Raymond Purves Bone and Joint Research Laboratories underscores his commitment to education and nurturing the next generation of researchers. This combination of research and teaching excellence enhances his candidacy for the award.

Publication Top Notes

  • πŸ“š “Are animal models useful for studying human disc disorders/degeneration?”
    • European Spine Journal 17, 2-19
    • Cited by: 854
    • Year: 2008
  • πŸ“˜ “Diverse cell signaling events modulated by perlecan”
    • Biochemistry 47 (43), 11174-11183
    • Cited by: 319
    • Year: 2008
  • πŸ”¬ “Increased nerve and blood vessel ingrowth associated with proteoglycan depletion in an ovine anular lesion model of experimental disc degeneration”
    • Spine 27 (12), 1278-1285
    • Cited by: 255
    • Year: 2002
  • 🧬 “Proteoglycan degradation by the ADAMTS family of proteinases”
    • Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (12)
    • Cited by: 249
    • Year: 2011
  • πŸ” “Keratan sulfate, a complex glycosaminoglycan with unique functional capability”
    • Glycobiology 28 (4), 182-206
    • Cited by: 226
    • Year: 2018
  • 🦴 “Proteoglycan 4 downregulation in a sheep meniscectomy model of early osteoarthritis”
    • Arthritis research & therapy 8, 1-6
    • Cited by: 200
    • Year: 2006
  • πŸ’‰ “Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors”
    • Journal of Biological Chemistry 277 (17), 14657-14665
    • Cited by: 200
    • Year: 2002
  • πŸ”— “A comparative analysis of the differential spatial and temporal distributions of the large (aggrecan, versican) and small (decorin, biglycan, fibromodulin) proteoglycans of the…”
    • The Journal of Anatomy 198 (1), 3-15
    • Cited by: 194
    • Year: 2001
  • 🧠 “Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms”
    • Journal of vascular surgery 24 (1), 82-92
    • Cited by: 173
    • Year: 1996
  • πŸ“ˆ “Comparative spatial and temporal localisation of perlecan, aggrecan and type I, II and IV collagen in the ovine meniscus: an ageing study”
    • Histochemistry and cell biology 124, 225-235
    • Cited by: 164
    • Year: 2005

Conclusion

Prof. James Melrose’s extensive research experience, numerous awards, and significant contributions to biochemistry and spine research make him a highly deserving candidate for the Research for Best Researcher Award. His roles in teaching and mentoring further solidify his position as a leader in his field, making a lasting impact on both research and education.